Guanabenz

Source: Wikipedia, the free encyclopedia.
(Redirected from
Guanabenz acetate
)
Guanabenz
Clinical data
Trade namesWytensin
AHFS/Drugs.comConsumer Drug Information
MedlinePlusa686003
ATC code
  • none
Pharmacokinetic data
Protein binding90%
Elimination half-life6 hours
Identifiers
  • 2-(2,6-dichlorobenzylidene)hydrazinecarboximidamide
JSmol)
  • Clc1cccc(Cl)c1\C=N\N=C(/N)N
  • InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+ checkY
  • Key:WDZVGELJXXEGPV-YIXHJXPBSA-N checkY
  (verify)

Guanabenz (pronounced GWAHN-a-benz, sold under the trade name Wytensin) is an

antihypertensive drug used in the treatment of high blood pressure (hypertension).[1][2]

The most common side effects during guanabenz therapy are

Guanabenz can make one drowsy or less alert, therefore driving or operating dangerous machinery is not recommended.

Research

Guanabenz also has some anti-inflammatory properties in different pathological situations, including multiple sclerosis.[4]

Guanabenz was found in one study to exert an inhibitory effect by decreasing the abundance of the enzyme CH25H, a cholesterol hydroxylase linked to antiviral immunity. Therefore, it is suggested that the drug and similar compounds could be used to treat type I interferon-dependent pathologies and that the CH25H enzyme could be a therapeutic target to control these diseases,[5] including amyotrophic lateral sclerosis.

See also

References